Table E2.
Patient characteristics
| RV (n = 18) | RV-HBoV1 (n = 17) | HBoV1 (n = 13) | |
|---|---|---|---|
| Age (y), mean ± SD | 1.4 ± 0.6 | 1.6 ± 0.9 | 1.6 ± 0.7 |
| Male | 13 (72%) | 11 (65%) | 9 (64%) |
| Sensitized∗ | 8 (44%) | 3 (18%) | 7 (54%) |
| Aeroallergen | 5 (28%) | 2 (12%) | 0 (0%) |
| Food allergen | 8 (44%) | 3 (18%) | 7 (54%) |
| Eczema | 7 (39%) | 5 (29%) | 5 (36%) |
| Parental | |||
| Asthma | 2 (11%) | 2 (12%) | 3 (21%) |
| Allergy | 10 (56%) | 10 (59%) | 11 (79%) |
| Smoking | 10 (56%) | 3 (18%) | 7 (50%) |
| First wheeze | 10 (56%) | 12 (71%) | 10 (77%) |
| Recurrent wheezing† | 12 of 16 (75%) | 5 of 11 (46%) | 5 of 11 (46%) |
Values are expressed as mean ± SD or n (%). The overall differences between virus groups were tested by using the chi-square test: all P > .10.
∗
Allergen-specific IgE > 0.35 kU/L.
†
After study entry, P = .19 for overall group comparisons.